Physician profile
Francis E Lee
NPI 1336645159
$1,991.56
in general payments reported to CMS, 2019-2025
12 companies · $807 in 2025
The $807 reported for 2025 was more than what 85% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $172 · 2024: $1,012 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $532.11 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $323.98 | 2023-2025 | Relistor, Trulance |
| Alkermes, INC. | $312.67 | 2023-2025 | Vivitrol, Vivitrol |
| Stryker Corporation | $233.58 | 2024 | Mako |
| Vertex Pharmaceuticals Incorporated | $159.66 | 2025 | |
| Indivior INC. | $128.02 | 2024-2025 | Sublocade |
| Valinor Pharma, LLC | $108.50 | 2023-2024 | Movantik |
| Lundbeck LLC | $74.52 | 2024-2025 | Vyepti |
| Pfizer INC. | $59.21 | 2025 | |
| Painteq LLC | $25.04 | 2023 | Painteq |
| Lilly USA, LLC | $17.89 | 2024 | Emgality |
| Tonix Medicines, INC. | $16.38 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.